Increase in de novo allergies after paediatric liver transplantation: the Brisbane experience

C Noble1, J Peake, P J Lewindon

  • 1Royal Children's Hospital, Herston, Brisbane Department of Paediatrics and Child Health, University of Queensland, Herston, Qld, Australia.

Insights

Serious allergic disease is common after pediatric liver transplantation (OLT), affecting 40% of survivors. Infants undergoing OLT are particularly at risk for de novo food allergies, requiring specialist management.

Area of Science:

  • Pediatric Gastroenterology
  • Transplant Immunology
  • Allergy and Immunology

Background:

  • Pediatric liver transplantation (OLT) offers a 10-year survival rate of 70%, with a focus on post-transplant quality of life.
  • Allergic disorders are increasingly prevalent, with a noted rise in food allergies post-solid organ transplantation, particularly in children.
  • The impact of de novo allergies on morbidity following pediatric OLT has not been well-defined.

Purpose of the Study:

  • To determine the incidence of de novo allergies that develop after pediatric liver transplantation.
  • To assess the contribution of these allergies to morbidity in pediatric OLT recipients.

Main Methods:

  • A comprehensive review of medical records was conducted for pediatric liver transplant recipients over an 11-year period.
  • Data collected included patient demographics, transplant details, and documented allergic conditions post-transplantation.

Main Results:

  • Of 60 pediatric OLT survivors, 24 (40%) developed documented allergic disease.
  • De novo food allergies were diagnosed in 12 (20%) survivors, with 9 of these occurring in infants at the time of transplant.
  • Severe allergies, including anaphylaxis, were noted in 10 of the 12 children with food allergies, highlighting a significant risk.

Conclusions:

  • Clinically significant allergic disease, especially de novo food allergies in infants post-OLT, is a critical concern.
  • These findings underscore the need for targeted specialist allergist referral and proactive risk management strategies for at-risk pediatric OLT patients.
Abstract

Related Concept Videos

Allergic Drug Reactions01:27

Allergic Drug Reactions

Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing numerous...
Allergic Reactions02:06

Allergic Reactions

Overview
Drug Toxicity: Allergic Reactions01:30

Drug Toxicity: Allergic Reactions

Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...
Allergic Reactions: Anaphylaxis01:30

Allergic Reactions: Anaphylaxis

Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin, heparin),...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...